We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


WuXi AppTec Passes FDA Inspection

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "WuXi AppTec Passes FDA Inspection"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

WuXi AppTec has announced that WuXi Lab Testing Division (LTD)’s late-and commercial-stage analytical and stability testing facilities in Shanghai successfully passed an FDA inspection for GMP compliance.

The inspector from FDA China office evaluated WuXi LTD’s quality system during a 4-day inspection, with focus on data integrity and compliance across its GMP analytical and stability testing facilities.

The inspection outcome confirmed WuXi’s adherence to FDA’s rigorous GMP guidance and its high quality of operation.

“FDA expects the highest quality and data integrity, and we are proud to receive a very positive feedback, ”said Dr. Ge Li, Chairman and CEO of WuXi AppTec, “ We will continue to uphold the highest quality standards and provide best-in-class R&D services for our customers worldwide.”